Blog

Self-collected HPV tests now the majority choice

A new National Cancer Screening Register report has found an increase in uptake of self-collected cervical screening tests and that the program is more effectively targeting vulnerable groups, despite declining HPV test volumes.  
“We are seeing around 50% of all cervical screens happening in Australia being done by women who are self-collecting,” assistant minister for health and aged care Rebecca White said.  
However, with eight of 10 children aged up to 15 years now vaccinated, she called for higher vaccination rates. 
“We want that to be much higher because this is a really simple vaccination program that’s proven effective and a great public health measure that celebrates its 20th year this year,” she said.  
Among participants with at least two HPV screening tests, the share who moved from a clinician-collected test to a self-collected test rose from 4% in 2022 to 42% in 2026. 
Between mid-2022 and mid-2026, self-collection among under-screened people aged 30 to 74 and more than two years overdue climbed from approximately 15% to 67.68%.  
For those with no prior screening and aged 30 to 74 years, the rate increased similarly from less than 15% to 65.55%.  

Related   

Women’s health: the unintended casualty of MBS simplification?

Clinicians invited to help shape cervical screening reform

Self-collection reshapes cervical screening in Australia

Self-collection rose with age, peaking among women aged 70 to 74, at 57.97%.  
Victorian obstetrician and president of the Royal Australasian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Dr Nisha Khot told The Medical Republic that it was “very positive” to see the increase in self-collection, particularly among previously under-screened or unscreened patients. 
Among women with HPV 16-18-positive results, most (81%) had a colposcopy follow-up within six months, and this pattern was similar for clinician-collected and self-collected samples. Only after six months was follow-up significantly higher for clinician-collected tests. 
Approximately 83.5% of participants, or one in five, had a liquid-based cytology (LBC) test within six months of receiving an HPV non-16-18 result. However, this left roughly one in six without one.  
The proportion of self-collected tests continued to rise, with the highest uptake in very remote areas, which accounted for 68.43% of cervical screenings, while major cities had the lowest proportion at 51.12%. 
Tasmania had the highest uptake of self-collection, followed by the Northern Territory. Every jurisdiction except the ACT recorded a self-collected share above 50%.  
Dr Khot said take-home self-screening tests were beneficial for women in the most remote areas, who often had to wait longer to see a healthcare provider or did not have a regular provider. However, she said it also indicated that there may be no doctors or nurses available to carry out the examination or, where necessary, a follow-up.  
Self-collected tests were often more accurate, with more HPV virus present lower down in the genital tract than higher up, she said.  
According to the report, following a 2020 spike, HPV positivity increased slightly across both collection methods in 2026, with a higher rate in self-collected samples (10.5%) than in clinician-collected samples (8.65%). 
However, a clinician examination could detect cancer, although very rare, she said, or cervical polyps otherwise undetectable by the self-collected test.  
Symptoms including bleeding between periods or after sex were often more serious signs requiring a clinical examination, she said.  
“I think we need to remember that there might be certain groups of people for whom a self-collect might not be easy to access,” Dr Khot said.  
This pertained particularly to women with disabilities, who often faced additional barriers in accessing screenings.  
Dr Khot said GPs could support patients with disabilities by either conducting a less invasive self-collected test for those who were hesitant, or by supporting them in carrying out their own test.  
“There is such a high prevalence of sexual abuse and trauma that is often not known,” the RANZCOG president said.  
Self-collected tests were also often a far less traumatic option for patients without completely disincentivising participation, she told TMR.   
Read the full report here.  
The post Self-collected HPV tests now the majority choice appeared first on Medical Republic.